Search Results

A Single-Blind Placebo Run-In Study of Venlafaxine XR for Activity-Limiting Osteoarthritis Pain

Authors: Sullivan, Mark; Bentley, Susan; Fan, Ming-Yu; Gardner, Greg

Source: Pain Medicine, Volume 10, Number 5, July/August 2009 , pp. 806-812(7)

Publisher: Blackwell Publishing

Brain Functional Changes and Duloxetine Treatment Response in Fibromyalgia: A Pilot Study

Authors: Hunter, Aimee M.; Leuchter, Andrew F.; Cook, Ian A.; Abrams, Michelle; Siegman, Barbara E.; Furst, Daniel E.; Chappell, Amy S.

Source: Pain Medicine, Volume 10, Number 4, May/June 2009 , pp. 730-738(9)

Publisher: Blackwell Publishing

Duloxetine: In Patients with Fibromyalgia

Author: Curran, Monique P.

Source: Drugs, Volume 69, Number 9, 18 June 2009 , pp. 1217-1227(11)

Publisher: Adis International

Antidepressants and Sleep: A Review

Author: Holshoe, Joseph M.

Source: Perspectives in Psychiatric Care, Volume 45, Number 3, July 2009 , pp. 191-197(7)

Publisher: Blackwell Publishing

Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

Authors: Carter, Natalie J.; McCormack, Paul L.

Source: CNS Drugs, Volume 23, Number 6, 30 May 2009 , pp. 523-541(19)

Publisher: Adis International

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1559-1562(4)

Publisher: Bentham Science Publishers

Desvenlafaxine: a new antidepressant or just another one?

Author: Pae, Chi-Un

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 5, April 2009 , pp. 875-887(13)

Publisher: Informa Healthcare

Dose-Finding Study of Fluoxetine and Venlafaxine for the Treatment of Self-Injurious and Stereotypic Behavior in Rhesus Macaques (Macaca mulatta)

Authors: Fontenot, M Babette; Musso, Mandi W.; McFatter, Robert M.; Anderson, George M.

Source: Journal of the American Association for Laboratory Animal Science, Volume 48, Number 2, March 2009 , pp. 176-184(9)

Publisher: American Association for Laboratory Animal Science

QSAR study on dual SET and NET reuptake inhibitors: An insight into the structural requirement for antidepressant activity

Author: Dessalew, Nigus

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 24, Number 1, February 2009 , pp. 262-271(10)

Publisher: Informa Healthcare

Current Considerations in the Treatment of Generalized Anxiety Disorder

Author: Katzman, Martin A.

Source: CNS Drugs, Volume 23, Number 2, 2009 , pp. 103-120(18)

Publisher: Adis International

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

Authors: Wasan, Ajay D.; Ossanna, Melissa J.; Raskin, Joel; Wernicke, Joachim F.; Robinson, Michael J.; Hall, Jerry A.; Edwards, Sara E.; Lipsius, Sarah; Meyers, Adam L.; McCarberg, Bill H.

Source: Current Drug Safety, Volume 4, Number 1, January 2009 , pp. 22-29(8)

Publisher: Bentham Science Publishers

Room for Improvement in the Pharmacological Treatment of Anxiety Disorders

Author: Baldwin, D. S.

Source: Current Pharmaceutical Design, Volume 14, Number 33, November 2008 , pp. 3482-3491(10)

Publisher: Bentham Science Publishers

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Authors: Fishbain, David A.; Detke, Michael J.; Wernicke, Joachim; Chappell, Amy S.; Kajdasz, Daniel K.

Source: Current Medical Research and Opinion, Volume 24, Number 11, November 2008 , pp. 3105-3115(11)

Publisher: Informa Healthcare

Desvenlafaxine Extended Release

Authors: Yang, Lily P.H.; Plosker, Greg L.

Source: CNS Drugs, Volume 22, Number 12, 2008 , pp. 1061-1069(9)

Publisher: Adis International

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

Authors: Liebowitz, Michael R.; Manley, Amy L.; Padmanabhan, Sudharshan K.; Ganguly, Rita; Tummala, Raj; Tourian, Karen A.

Source: Current Medical Research and Opinion, Volume 24, Number 7, July 2008 , pp. 1877-1890(14)

Publisher: Informa Healthcare

Progesterone Pretreatment Enhances Serotonin-Stimulated BDNF Gene Expression in Rat C6 Glioma Cells Through Production of 5α-Reduced Neurosteroids

Authors: Morita, Kyoji; Her, Song

Source: Journal of Molecular Neuroscience, Volume 34, Number 3, March 2008 , pp. 193-200(8)

Publisher: Humana Press

Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants: A Systematic Review and Meta-Analysis

Authors: Nakagawa, Atsuo; Watanabe, Norio; Omori, Ichiro M.; Barbui, Corrado; Cipriani, Andrea; McGuire, Hugh; Churchill, Rachel; Furukawa, Toshi A.

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 587-602(16)

Publisher: Adis International

Spotlight on Bupropion in Major Depressive Disorder

Authors: Dhillon, Sohita; Yang, Lily P.H.; Curran, Monique P.

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 613-617(5)

Publisher: Adis International

Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test

Authors: Jama, A.; Cecchi, M.; Calvo, N.; Watson, S.; Akil, H.

Source: Psychopharmacology, Volume 198, Number 3, June 2008 , pp. 333-340(8)

Publisher: Springer

Multitarget Selective Antidepressants Design: Latest Developments, Opportunities and Challenges

Authors: Dessalew, Nigus; Mikre, Workalemahu; Hymete, Ariaya

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 8, Number 2, June 2008 , pp. 131-142(12)

Publisher: Bentham Science Publishers